Shandong Qilu

Qilu Pharmaceutical is a leading vertically integrated Chinese pharmaceutical company headquartered in Jinan, Shandong. The company specializes in the development, manufacturing, and marketing of active pharmaceutical ingredients (APIs) and finished dosage forms across various therapeutic areas, including oncology, infectious diseases, and cardiovascular health. While historically known for its robust generics and biosimilars portfolio, Qilu has significantly expanded into innovative drug discovery, focusing on monoclonal antibodies, small molecules, and cell therapies. With a global footprint and extensive manufacturing capabilities, it serves as a major player in both the domestic Chinese market and international markets. The company operates multiple R&D centers globally, including sites in the United States, to drive its transition toward an innovation-led business model.